In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seno gets $2m in state funding:

This article was originally published in Clinica

Executive Summary

Opto-acoustic technology specialist Seno Medical Instruments has been awarded $2m from the Texas Emerging Technology Fund (TETF), a $200m government investment programme aimed at financing local advancing technology projects. This investment allows San Antonio, Texas-based Seno to further develop its breast cancer imaging technology, and work towards implementing initial clinical trials on technology at the Cancer Therapy and Research Center, and the University of Texas Health Science Center. The company is aiming to provide a device that uses optics and acoustics, instead of x-ray radiation, to capture an accurate image of a tumour.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel